Search

Home > Industry Focus > Healthcare: Alkermes Super-Bad Day, and Illumina's Surprising M&A News
Podcast: Industry Focus
Episode:

Healthcare: Alkermes Super-Bad Day, and Illumina's Surprising M&A News
Category: Business
Duration: 00:26:35
Publish Date: 2018-11-07 20:30:00
Description:

Why Alkermes once-promising depression drug failed to impress the FDA's advisory committee. Plus, how a $1.2 billion acquisition of Pacific Biosciences could move the needle at Illumina. Stocks: ALKS, ILMN, PACB
Total Play: 0

Users also like

0 Episodes
MarketFooler .. 100+     6
700+ Episodes
Rule Breaker .. 200+     6
2K+ Episodes
Motley Fool .. 300+     10+

Some more Podcasts by The Motley Fool

300+ Episodes
Motley Fool ..    
700+ Episodes
Rule Breaker .. 200+     6
400+ Episodes
Motley Fool .. 100+     5
2K+ Episodes
Motley Fool .. 300+     10+
2K+ Episodes
Motley Fool ..